Scholarly Index
David M. Smadja
Inserm; 12,783 total citations; 343 total publications; best world rank #20
Inserm
12,783Total citations
343Total publications
49H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| COVID-19 Clinical Research Studies | Lifetime | 353 | FR 17 | 98.49 |
| Long-Term Effects of COVID-19 | Lifetime | 448 | FR 26 | 96.60 |
| COVID-19 and healthcare impacts | Lifetime | 355 | FR 8 | 95.55 |
| Angiogenesis and VEGF in Cancer | Lifetime | 518 | FR 17 | 96.93 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 700 | FR 42 | 96.88 |
| Vascular Anomalies and Treatments | Lifetime | 430 | FR 48 | 90.78 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 728 | FR 57 | 88.48 |
| COVID-19 Clinical Research Studies | 2021-2025 | 216 | FR 9 | 98.88 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 20 | FR 2 | 94.70 |
| COVID-19 and healthcare impacts | 2021-2025 | 368 | FR 8 | 94.10 |
| Long-Term Effects of COVID-19 | 2021-2025 | 681 | FR 28 | 94.57 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 485 | FR 32 | 94.99 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 133 | FR 4 | 91.04 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 125 | FR 10 | 86.63 |
| Cell Adhesion Molecules Research | 2021-2025 | 330 | FR 12 | 81.81 |
| Mesenchymal stem cell research | 2021-2025 | 720 | FR 11 | 84.27 |